ルイジアナ州における転移性癌の臨床試験
ルイジアナ州内の拠点で、転移性癌に関する20件の研究が参加者を募集しています。
ルイジアナ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ochsner Medical Center Jefferson, New Orleans
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- East Jefferson General Hospital, Metairie
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Pontchartrain Cancer Center, Covington
- Pontchartrain Cancer Center, Hammond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Ochsner Clinic Foundation, New Orleans
- Trials 365, Shreveport
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Mary Bird Perkins Cancer Center, Baton Rouge
- Mary Bird Perkins Cancer Center - Metairie, Metairie
- Ochsner Clinic Foundation, New Orleans
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Our Lady of the Lake RMC, Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- Ochsner Medical Center Jefferson, New Orleans
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06311214Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Care Access-Marrero, Marrero
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Mary Bird Perkins Cancer Center, Baton Rouge
- Ochsner Clinic Foundation, New Orleans
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Metairie
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07129252A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Our Lady of the Lake, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Ochsner Health, New Orleans
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Ochsner Health, Jefferson
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/18更新 · NCT07094204Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- Ochsner Clinic Foundation, New Orleans
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/19更新 · NCT05270213SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。